Soleno Therapeutics, Inc. (SLNO) News

Soleno Therapeutics, Inc. (SLNO): $45.12

4.11 (-8.35%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SLNO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#288 of 358

in industry

Filter SLNO News Items

SLNO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SLNO News Highlights

  • SLNO's 30 day story count now stands at 5.
  • Over the past 7 days, the trend for SLNO's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • SNAP and TOP are the most mentioned tickers in articles about SLNO.

Latest SLNO News From Around the Web

Below are the latest news stories about SOLENO THERAPEUTICS INC that investors may wish to consider to help them evaluate SLNO as an investment opportunity.

Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

Yahoo | December 21, 2023

Growth Stocks Under $50 for December 2023

These are seven of the best-performing growth stocks for December 2023 based on above-average returns.

Yahoo | December 15, 2023

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

These three stocks to take profits on rallied more than 200% this year.

Ian Bezek on InvestorPlace | December 14, 2023

3 Stock Winners That Are Up 500% or More in 2023

If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January

Jeremy Flint on InvestorPlace | December 14, 2023

Insider Sell Alert: CEO Bhatnagar Anish Unloads 93,408 Shares of Soleno Therapeutics Inc (SLNO)

In a notable insider sell transaction, CEO Bhatnagar Anish of Soleno Therapeutics Inc (NASDAQ:SLNO) parted with 93,408 shares of the company on December 11, 2023.

Yahoo | December 14, 2023

7 Stock Winners That Are Up 1,000% or More in 2023

Could any or all of these seven stocks up 1000% this year go on another hot run during 2024?

Thomas Niel on InvestorPlace | December 12, 2023

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Thomas Yeung on InvestorPlace | December 4, 2023

Insider Sell Alert: CFO James Mackaness Sells 8,081 Shares of Soleno Therapeutics Inc (SLNO)

James Mackaness, the Chief Financial Officer of Soleno Therapeutics Inc, has recently made a significant change in his holdings of the company's stock.

Yahoo | December 1, 2023

Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.

When investors land on a "jackpot" stock, gains can offset even the steepest losses.

Thomas Yeung on InvestorPlace | November 27, 2023

3 Biotech Stocks With Big-Time Breakthrough Potential

In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area.

Gabriel Osorio-Mazzilli on InvestorPlace | November 20, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!